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ABSTRACT
Objective To identify what outcomes have been assessed 
in traumatic brachial plexus injury (TBPI) research to 
inform the development of a core outcome set for TBPI.
Design Systematic review.
Method Medline (OVID), EMBASE, CINAHL and AMED 
were systematically searched for studies evaluating the 
clinical effectiveness of interventions in adult TBPIs from 
January 2013 to September 2018 updated in May 2021. 
Two authors independently screened papers. Outcome 
reporting bias was assessed. All outcomes were extracted 
verbatim from studies. Patient- reported outcomes or 
performance outcome measures were extracted directly 
from the instrument. Variation in outcome reporting was 
determined by assessing the number of unique outcomes 
reported across all included studies. Outcomes were 
categorised into domains using a prespecified taxonomy.
Results Verbatim outcomes (n=1491) were extracted 
from 138 studies including 32 questionnaires. Unique 
outcomes (n=157) were structured into 4 core areas and 
11 domains. Outcomes within the musculoskeletal domain 
were measured in 86% of studies, physical functioning in 
25%, emotional functioning in 25% and adverse events 
in 33%. We identified 63 different methods for measuring 
muscle strength, 16 studies for range of movement and 
63 studies did not define how they measured movement. 
More than two- thirds of the outcomes were incompletely 
reported in prospective studies.
Conclusion This review of outcome reporting in 
TBPI research demonstrated an impairment focus 
and heterogeneity. A core outcome set would ensure 
standardised and relevant outcomes are reported to 
facilitate future systematic review and meta- analysis.
PROSPERO registration number CRD42018109843.
INTRODUCTION
A traumatic brachial plexus injury (TBPI) is 
a major injury to the brachial plexus. It can 
result in significant functional, social, psycho-
logical and economic effects,1 2 with most 
occurring in young men as a result of motor-
bike accidents.3 Survival from major trauma 
is increasing,4 and with this an increase in the 
incidence of TBPI,5 which accounts for 1.2% 
of polytrauma.6The complex and chronic 
nature of the injury is associated with signifi-
cant healthcare costs,7 in addition to indirect 
costs estimated at up to US$2.34 million (in 
2017 US dollars) over the lifetime of a manual 
labourer in the USA with a TBPI.8 There are 
multiple strategies for managing a patient 
with a TBPI with recent advancements in 
nerve microsurgery9 and robotics,10 resulting 
in increased treatment options. The choice of 
treatment should be made using up- to- date, 
high- quality scientific evidence.11 12
Ideally, a meta- analysis would identify the 
most effective treatment for an individual 
with a TBPI, however, such analysis requires 
homogenous outcome measurement and 
reporting across studies to enable optimum 
synthesis. Indeed, despite increasing numbers 
of TBPI studies, outcome heterogeneity and 
poorly defined outcomes have been high-
lighted as a significant challenge to evidence 
synthesis in two recent systematic reviews.13 14 
There is now an international agreement that 
the definition of a core outcome set (COS) 
for TBPI is a priority.15 16 A COS is a minimum 
agreed set of outcomes to be reported and 
measured in all studies.17 18 Development of 
a COS has been shown to reduce heteroge-
neity of outcome reporting in other health 
conditions, with 81% of trialists in rheuma-
toid arthritis (RA) now measuring the COS 
for RA.19
Strengths and limitations of this study
 ► This study is a comprehensive and systematic re-
view of clinical outcomes reported in the traumatic 
brachial plexus studies from 2013 to 2021 inclusive.
 ► Unique outcomes were systematically categorised 
into a clear taxonomy to inform the development of 
a core outcome set.
 ► Definition of unique outcomes and categorisation 
were conducted by researchers and clinicians to ac-
count for multidisciplinary perspectives.
 ► Outcome reporting bias was assessed in included 
prospective and randomised controlled trials.
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To date a minimum set of outcomes, important to 
patients and professionals for reporting in TBPI studies, 
has not been agreed. The choice of what are important 
outcomes to measure in TBPI is complex due to patient 
heterogeneity with different mechanisms, locations and 
severity of injury. COS methodology is continuously being 
refined and promoted by the Core Outcome Measures 
in Effectiveness Trials (COMET) initiative.20 Develop-
ment of a COS usually begins with identification of a 
long list of outcomes which is then prioritised through 
a consensus process. This systematic review sits within 
the larger global COMBINE (Core Outcome Measures 
in Brachial plexus INjuriEs) project to identify a COS for 
TBPI. A Delphi study and consensus meeting, informed 
by data from this systematic review and interviews with 
people with the injury, will prioritise the final COS for 
TBPI.
As a first step in the development of an international 
COS for TBPI, we conducted a systematic review to iden-
tify outcomes reported and measurement instruments 
used and their timing in the literature. The final step 
of the global project will match the COS to existing vali-
dated measurement instruments and make recommenda-
tions on when they should be collected, therefore it was 
necessary to identify currently used instruments and their 
timepoints also.
The aims of this review were as follows:
1. Identify what outcome domains are assessed in stud-
ies evaluating surgical and non- surgical treatment for 
TBPI.
2. Compare the definitions of outcomes and timepoints 
of outcomes assessed.
3. Assess selective reporting bias in included prospective 
studies and randomised controlled trials.
4. Identify how the outcomes were measured, that is, 
what validated or non- validated instruments are used.
METHODS
We followed the methods described in the Cochrane 
Handbook for Systematic Reviews of Interventions,21 and 
report in accordance with the Preferred Reporting Items 
for Systematic Reviews and Meta- Analysis (PRISMA) 
guidelines.22 Deviations from the protocol are reported 
in online supplemental file 1.
Identification of studies
We conducted an electronic search of Medline (OVID), 
EMBASE (OVID), CINAHL and AMED on 18 September 
2018. Studies published between 1 January 2013 and 
18 September 2018 were included to reflect outcomes 
employed in current TBPI care. An example of the search 
strategy for Ovid MEDLINE is presented in online supple-
mental file 2. The thesaurus vocabulary of each database 
was used to adapt search terms. Boolean operators (AND, 
OR) were used to narrow or widen the search and no 
language restrictions were applied. The search was re- run 
on 7 May 2021 to identify any additional outcomes.
Study eligibility
Studies were included if they met the following criteria:
Study type
Any controlled and uncontrolled experimental and 
observational studies evaluating interventions in TBPI 
including case reports, case series, case studies, prospec-
tive and retrospective cohort studies, randomised and 
non- randomised clinical trials. When the search was 
re- run in May 2021, only prospective cohort and clinical 
trials were included. We excluded conference proceed-
ings, abstract only publications and those not involving 
human subjects.
Participants
Studies reporting outcomes in individuals with TBPI 
aged ≥16 years. Studies of patients with obstetric brachial 
plexus injuries were excluded.
Interventions
Any surgical or non- surgical intervention for TBPI.
Outcomes
All outcomes reported in the published abstract, methods 
or results. These included physiological and functional 
outcomes, adverse events and patient- reported outcomes 
(PROs) either reported in the study or subsequently 
extrapolated from the PRO instruments.
Language
Non- English language publications were included.
Study selection process
The reference management software Mendeley was 
used to compile the literature, with duplicates removed. 
Authors (CM and JOS) independently screened the titles 
and then the abstracts against the eligibility criteria. 
Disagreements were discussed and a third reviewer (CJH) 
was involved when required. Studies appearing to meet 
the inclusion criteria based on title and abstract were 
retrieved as full- text articles, and were read to assess 
for eligibility with decisions on inclusion and exclusion 
recorded. Disagreements in study selection were resolved 
by discussion within the research team (CM, JCand CJH).
Quality assessment
The aim of this review was to identify outcomes reported 
in studies rather than synthesise data on intervention 
effectiveness. However, selective outcome reporting can 
provide information on what outcomes authors prioritise. 
We used a modified version of the matrix by Kirkham et 
al23 24 to assess outcome reporting bias (ORB) in prospec-
tive studies and randomised controlled trials (see ORB 
instrument in online supplemental file 3). Two indepen-
dent reviewers (CM and JOS) performed the assessment 
of ORB for all outcomes.
Data extraction
Data were extracted into a piloted data extraction sheet 
(Microsoft Excel). General data extracted from each 
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study included author, study design, recruiting country, 
publication year, number of participants, gender, mean 
age, level of TBPI and intervention tested. The following 
information was extracted regarding outcomes: each 
outcome reported (verbatim), area of body assessed 
if relevant (shoulder, elbow, wrist or hand), method of 
administration, name of measure, timepoints of measure 
and reported complications. The number of outcomes 
per study was also documented.
Data extraction was performed independently by CM 
and JOS for the first 20% of included studies. These were 
compared, and disagreements discussed and resolved 
through debate or discussion with a third reviewer (CJH). 
Following this a further 10% of studies had data extracted 
by both CM and JOS. Owing to the high level of agree-
ment between reviewers (91% agreement) on outcomes 
extracted, at this stage, the remaining studies underwent 
extraction by a single reviewer (CM).
Where a validated PRO or performance outcome 
measurement was used and composed of multiple items, 
the following data were extracted by the first author: 
verbatim name of the instrument, verbatim wording for 
each individual item. A performance outcome measure-
ment was defined as ‘A measurement based on a stan-
dardized task performed by a patient that is administered 
and evaluated by an appropriately trained individual or 
is independently completed’.25 The frequency of use of 
instruments was noted and compared between studies. 
The instruments were categorised as: (1) general health 
(generic—for use with any patient); (2) upper limb phys-
ical function (region- specific); (3) symptom or domain 
specific (to assess a single symptom, eg, pain) and (4) 
condition specific. Timepoints of measurement of all 
outcomes were noted. If the outcome was assessed at 
different timepoints, then all timings were recorded.
Classification of outcomes into domains and defining unique 
outcomes
Identically worded and spelled verbatim outcomes were 
removed at this stage. Identical outcomes measured over 
Figure 1 Preferred Reporting Items for Systematic Reviews and Meta- Analysis flow diagram.
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different time points were noted as one outcome. Where 
outcomes were assessed using an instrument containing 
several items, each individual item was assigned an 
outcome name using the International Classification of 
Functioning and following standard linking rules.26
CM categorised all outcomes into an outcome taxonomy 
developed by COMET for categorising outcomes for 
COS development.27 These included 5 core areas and 
38 outcome domains. This is presented in online supple-
mental file 4. A long list of all categorised outcomes was 
presented to researchers (JC and CJH) at a face- to- face 
meeting where the categorisation of all outcomes was 
reviewed using the recommended taxonomy. Subdo-
mains were created within the larger taxonomy to manage 
the large variation in TBPI clinical outcomes extracted. 
Disagreements not resolved at this stage were discussed 
further with subject experts (eg, the adverse event domain 
was discussed with a surgeon).
Owing to the diversity in terminology used to report 
outcomes, we grouped similar outcomes within each 
subdomain. It is recommended that outcomes with 
different words, phrasing or spelling addressing the same 
concept should be categorised as a unique outcome.28 
For example, active range of motion of shoulder abduc-
tion and active goniometry of shoulder abduction were 
named as active shoulder abduction range and grasp 
strength and grip strength were named as grip strength. 
Independent meetings were held with four subject experts 
to ratify and define unique outcome names within each 
domain.
Patient and public involvement
The need for a COS in TBPI care was conceived following 
discussions with patients and health professionals. 
Patients highlighted the diverse effect the injury has 
on their life and that often these outcomes were over-
looked by professionals, such as body image. There is a 
patient advisory group for the COS and the systematic 
review was discussed at these meetings. Patients were 
not actively involved in data collection or analysis of this 
review. Dissemination will occur at the annual traumatic 
brachial plexus charity UK meeting where updates from 




The search retrieved 2819 studies, after removing dupli-
cates 2051 studies remained.
Title and abstract review identified 243 potentially 
relevant articles. Of these, 105 studies did not meet 
the inclusion criteria and were excluded (PRISMA 
flow diagram; figure 1); thus, 138 studies formed the 
basis of this review. All included studies are presented 
in online supplemental file 5.
Study characteristics
Thirty- three countries from six continents recruited 
3328 participants into the 138 studies (table 1). Of the 
Table 1 Characteristics and demographics of included 
studies
Study number (%)
Number of retrospective studies 87/138 (63)
Number of prospective studies 24/138 (17)
Number of case studies 23/138 (17)
Randomised controlled trial 4/138 (3)
World region recruitment
  Asia 62/138 (45)
  North America 20/138 (14)
  South America 23/138 (17)
  Europe 28/138 (20)
  Africa 3/138 (2.2)
  Australasia 2/138 (1.5)
Year published
  2013 25/138 (18)
  2014 24/138 (17)
  2015 15/138 (11)
  2016 30/138 (22)
  2017 27/138 (20)
  2018 11/138 (8)
  2019 (prospective only) 3/138 (2.2)
  2020 (prospective only) 2/138 (1.5)
  2021 (prospective only) 1/138 (0.7)
Gender (total 3328)
  Male 2737/3328 (82)
  Female 335/3328 (10)
  Not stated 256/3328 (7.7)
Site of plexus injury per study (n=138)
  Upper trunk 27/138 (20)
  Lower trunk 10/138 (7.2)
  Pan plexus (all avulsed) 52/138 (38)
  Infraclavicular 7/138 (5)
  Mixture 35/138 (25)
  Unclear 7/138 (5)
Interventions (n=138)
  Surgical 118/138 (86)
  Electrotherapy 3/138 (2.2)
  Pain treatments 11/138 (8)
  Rehabilitation 4/138 (2.9)
  Orthotic 1/138 (0.7)
  Stem cell 1/138 (0.7)
Types of surgical intervention (n=118)
  Neurotisation 66/118 (56)
  Tendon transfer 8/118 (6.8)
  Free flap 17/118 (14)
  Multiple surgeries 12/118 (10)
  Contralateral C7 8/118 (6.8)
  Other 7/118 (5.9)
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138 studies, 87 (63%) were retrospective case series 
with most studies published from Asia (n=62, 45%). 
The most frequently studied surgical intervention was 
neneuritisation (n=66, 56%).
Outcomes
Extraction of each verbatim outcome domain from 
each study (eg, range of movement and muscle 
strength) and those extracted from measures 
composed of several items identified a total of 1491 
verbatim outcomes. After removing duplicates, 157 
different unique outcomes remained. No single 
outcome was reported across all 138 studies.
Outcome definition variation
Many outcomes were not clearly defined and different 
terms were frequently found for the same concept. For 
example, shoulder abduction strength was described 
in 11 different ways including ‘deltoid strength’, 
‘motor function of axillary nerve’, ‘motor recovery of 
shoulder abductors’, ‘muscle power supraspinatus’, 
‘motor function of deltoid’ and ‘motor function of 
supraspinatus’.
Outcome timing variation
Forty per cent of outcomes were measured between 1 and 
3 years following intervention. For >6% of outcomes, the 
timing of the measurement was not stated (see figure 2).
Outcome domains
The 157 different types of outcomes were catego-
rised into 4 core areas (physiological and clinical, 
life impact, resource use, adverse events/compli-
cations) and 11 domains according to the COMET 
recommendations24 (see online supplemental file 6). 
The core area physiological/clinical included three 
domains: musculoskeletal and connective tissue 
outcomes, nervous system outcomes and general/
symptom outcomes. The core area, life impact, 
included seven domains: physical functioning, 
social functioning, role functioning, emotional 
functioning, global quality of life, perceived health 
status and delivery of care. The core area, resource 
use, included one domain: hospital resources. The 
core area, adverse events, included one domain: 
adverse events. No outcome could be placed into the 
core area, death.
Tables 2–4 summarise the number of unique 
outcomes within each domain and the number of 
studies reporting these outcomes in each core area. 
The most frequently reported domains were all in 
the physiological/clinical core area and included 
musculoskeletal and connective tissue (86%), nervous 
system (33%) and symptoms (38%). Forty- six studies 
(33%) reported complications/adverse events.
Outcome measurement
In addition to extraction of standalone clinician- 
reported outcomes and PROs such as muscle power, 
range or movement or return to work, outcomes 
were also extracted from individual items contained 
in a total of 32 different instruments; PRO measures 
(n=22), combined clinician- reported and patient- 
reported measures (n=3) and performance measures 
(n=7), see table 5. These measures were reported 98 
times in the included publications. Most outcome 
measures were used once (n=22/32, 69%). The most 
frequently reported measures were the Disabilities of 
the Arm Shoulder and Hand (DASH29) questionnaire 
(n=28 studies, 29%) and the Visual Analogue Scale 
(n=20, 20%). The median number of items per instru-
ment was 15 ranging from 1 (Visual Analogue Scale, 
Numerical Rating Scale and Wong Baker Faces Rating 
Figure 2 Outcome measurement timepoints.
Table 2 Physiological/clinical core area
Outcome domains
Number of unique outcomes 
reported within domain Examples of unique outcomes
Number of studies reporting 
outcomes in domain (%)
Musculoskeletal and 
connective tissue
18 Active range of movement, muscle 
strength, muscle fatigue
119/138 (86)
Nervous system 15 Progression of nerve regeneration, ability 
to feel light touch, ability to feel pain
46/138 (33)
General/ symptoms 23 Pain intensity/relief, pain duration, pain 
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Scale)30 to 54.31 These items mapped to 34 different 
outcome domains.
There was wide variation in the methods used to 
measure outcomes. This is presented in online supple-
mental file 7.
For example, 63 different measurements were 
used to evaluate muscle function, including the 
British Medical Research Council,32 12 different 
modifications of the British Medical Council, Isoki-
netics, Dynanometry and Constant- Murley score.33 
In addition, it was often not clear which instru-
ment was used for measurement of the outcomes. 
For example, the instrument used to measure active 
range of movement was not reported in 34% of total 
times (63/186) the outcome was assessed. Finally, 
with regards to method of measurement, 61 studies 
employed a PRO instrument to evaluate the inter-
vention. Prospective and randomised controlled 
trials were more likely to evaluate outcomes with a 
PRO (58%;15/26) compared with 36% (31/87) of 
retrospective studies.
Outcome reporting bias
Figure 3 illustrates the reporting status of outcomes 
(n=173) across the included prospective case series, 
cohort and randomised controlled studies (n=26). 
Fewer than one- third of the outcomes in the prospec-
tive case series and cohort studies and half of outcomes 
in randomised controlled studies were ‘completely’ 
reported.
DISCUSSION
This systematic review aimed to identify what outcome 
domains have been reported in studies evaluating inter-
ventions for TBPI, examine outcome definitions and 
timepoints and identify the instruments used to assess 
outcomes. We found a wide variation in the reported 
outcomes, timing of outcomes and outcome instruments 
used. Furthermore, a lack of standardised definition for 
commonly reported outcomes was observed. This hetero-
geneity in outcome reporting across studies hinders 
evidence synthesis and results in research waste.34
Table 3 Life impact core area
Outcome domains
Number of unique outcomes 
reported within domain Examples of unique outcomes
Number of studies reporting 
outcomes within domain (%)
Physical functioning 19 Reaching, fine hand movement 35/138 (25)
Role functioning 23 Return to work, impact on normal 
hobbies
38/138 (27)
Social functioning 7 Social activities with family 32/138 (23)
Emotional functioning 13 Body image, acceptance 34/138 (25)
Global quality of life 1 Quality of life 2/138 (1.5)
Perceived health 
status
1 Health status rating 9/138 (6)
Delivery of care 13 Patient satisfaction, quality of care, 
patient preference, time to surgery
11/138 (8)
Table 4 Adverse events and resource use core areas
Outcome domains
Number of unique outcomes 
reported within domain
Examples of unique 
outcomes
Number of studies reporting 
outcomes within domain (%)
Adverse events core area
Donor site morbidity 3 Motor weakness, sensory 
loss
24/138 (17)
Musculoskeletal 7 Co- contraction, passive 
movement
12/138 (8.7)
Respiratory 4 Pneumothorax 6/138 (4.4)
Vascular 7 Haematoma 7/138 (5.1)
Infection 1 Infection 3/138 (2.2)
General non- specified 
complications
1 General complications 3/138 (2.2)
Resource use core area
Hospital resource use 1 Operation time 1/138 (.7)
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The most commonly reported core area was physi-
ological/clinical including musculoskeletal, nervous 
system and symptom domains. Eighty- six per cent of the 
studies reported musculoskeletal outcomes. However, 
there were 21 different outcomes reported in this cate-
gory making comparison between studies difficult. 
Furthermore, the diversity of measures used to assess 
the outcomes increases the difficulty with synthesis. For 
example, muscle function/strength was assessed using 59 
different measures, while 10 studies did not report what 
measure they used. To compound this, muscle strength 
was assessed by both physical examination by a clinician 
(86%) and also by asking the patient(10%).
Only 44% of studies (61/138) evaluated PROs and 
within these studies there was significant heterogeneity in 
the measurement instrument used. Twenty- five different 







PRO measures Upper limb physical function measures (n=17)
  DASH 38 3 28
  Quick DASH 19 3 1
  Upper Extremity Functional Index 20 0 2
  American Shoulder and Elbow Score 15 0 1
  Modified American Shoulder and Elbow Score 13 0 1
  Simple Shoulder Test 12 0 1





  University of California Los Angeles Shoulder Score 5 0 1
  Constant- Murley 5 0 1
  Mayo Performance Index 4 0 1
Performance 
measures
  Jebsen Taylor 7 0 1
  University of New Brunswick Test of Prosthetic Function 
for Unilateral Amputees
30 3 1
  Upper Limb Module Questionnaire 22 3 1
  Action Reach Arm Test 19 4 2
  Southampton Hand Assessment Procedure 26 0 2
  Purdue Peg test 3 0 1
  Activities Measure for Upper Limb Amputees 24 0 1
PRO measures Generic questionnaires (n=3)
  36- item short- form survey 36 8 8
  Patient Specific Functional Score 4 0 2
  EuroQol-5 Dimension (EQ5D) 6 0 1
Condition- specific questionnaires (n=1)
  Trinity Amputation and Prosthesis Scale 54 5 1
Symptom- specific questionnaires (n=10)
  Visual Analogue Scale 1 0 20
  Numerical Rating Scale 1 0 6
  Wong Baker Faces Rating Scale 1 0 1
  Brief Pain Inventory 15 6 4
  Neuropathic Pain Symptom Inventory 10 5 1
  University of Washington Neuropathic Score 10 3 1
  McGill Pain Questionnaire 28 3 2
  McGill Pain Questionnaire Short- Form 17 3 1
  McGill Pain Questionnaire (Japanese version) 17 3 1
  Self- rating Anxiety Scale 20 0 1
  Zung Self- rating Depression Scale 20 0 1
DASH, Disabilities of Arm Shoulder and Hand; PRO, patient- related outcome.
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instruments were used with only 17 ever- used once. The 
DASH was the most common instrument employed, in 
almost half the studies evaluating a PRO. The PRO instru-
ments also varied greatly in terms of content with some 
as simple as a single item while others included up to 
54 items. Over 408 individual questionnaire items were 
evident from the 25 PRO instruments mapping to 34 
different outcomes domains. This highlighted a lack of 
consistency with no domain being measured by all PRO 
instruments. None of the included PRO assessments were 
designed specifically for individuals with a TBPI. Although 
this may be beneficial in terms of comparison with other 
conditions, such instruments may not be sensitive to issues 
of importance to patients with TBPI. Finally, it was evident 
that prospective studies and randomised controlled trials 
were more likely to use PROs to evaluate interventions. 
This may correspond with the higher methodological 
rigour associated with these study designs. However, the 
majority of studies evaluating interventions in TBPI were 
retrospective (63%). These issues combined pose major 
questions regarding the clinical interpretation of results 
from TBPI studies.
It is clear that that individuals with a TBPI suffer signifi-
cant emotional and psychosocial issues.1 35 However, such 
issues were infrequently and inconsistently measured 
within this review. Only two studies evaluated quality of 
life.36 37 Similarly, physical, role and social functioning 
outcomes were reported in 25%, 27% and 23% of studies, 
respectively. This relates strongly to the use of the DASH 
within the studies. Indeed, emotional functioning was 
reported in 34 studies, 28 of these studies used the DASH 
which has one item on confidence and capability mapping 
to this domain. If the DASH was excluded, only six studies 
would assess outcomes within the emotional functioning 
domain. This is surprising considering the existing litera-
ture which evidences the complex emotional and psycho-
logical factors, individuals face when adjusting to their 
injury.1 38
Complications/adverse events were reported in one- 
third of the studies. Documentation of complications 
is crucial to improve patient care and gather data for 
benchmarking. In 1992, the Clavien- Dindo classifi-
cation39 was introduced to assist with classification of 
complications to enable comparison between studies.39 
However, within the adverse events outcomes identified 
in this review there was heterogeneity. Of the 37 verbatim 
outcomes reported within the donor morbidity (motor) 
outcome, 19 did not define how this was assessed.
Outcome reporting bias
Only four studies included in this review were randomised 
controlled trials.40–43 However, despite prospective trial 
registration on a public registry being a condition of 
publication,44 none of the randomised trials on TBPI 
were registered. We also found marked selective outcome 
reporting in the included prospective and randomised 
TBPI studies. Most outcomes were only partially reported, 
frequently lacking specific detail about the outcome result 
or time of measurement, omitting certain outcome results 
or lacking detail needed for meta- analysis. This ORB iden-
tified in the current TBPI literature threatens the validity 
of the evidence- based practice in TBPI because it poten-
tially overestimates the effect of treatments or distorts 
results of studies. This contributes to research waste and 
critically delays advancement of care for patients.
There are some limitations in this review. We excluded 
outcomes from older studies to ensure we identified 
outcomes relevant to contemporary TBPI care. Detailed 
risk of bias assessment was not undertaken, however the 
review was designed to identify the breadth of reporting 
in the literature and not to examine the effectiveness of 
interventions. The strengths of this review are that the 
protocol and the data extraction form were prespeci-
fied, prospectively registered and the literature search 
systematic. To account for multidisciplinary perspectives, 
researchers and clinicians where involved in categorising 
outcomes into domains. It is the first review to detail the 
extent of outcome heterogeneity in TBPI research using a 
systematic method. International and non- English publi-
cations were included to reduce the risk of selection bias.
Variation in definitions and measurement of outcomes 
has been found within other areas of healthcare. Outcome 
heterogeneity is found in the reporting of outcomes 
relating to burn care,45 breast reconstruction46 and spinal 
cord injury,47 among others. A recent review of outcome 
reporting within burns illustrated wound healing was 
defined in 166 different ways across 147 studies.45 A solu-
tion to the variation in outcome reporting across studies 
in TBPI is the development of a COS.20 This has been 
shown to improve consistency of outcome reporting.19 48 
Development of a COS in TBPI would not restrict the 
range of outcomes that can be measured. Researchers 
and clinicians would still be free to select additional 
outcomes but the inclusion of such a COS would facili-
tate synthesis of evidence.49 50 While work has begun in 
obstetric brachial plexus injuries to develop a minimum 
dataset,51 there is no COS for TBPI.
Considerable work has been done by the COMET 
initiative through dissemination of resources for COS 
Figure 3 Cumulative bar chart showing number of 
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development and support for methodological develop-
ment. COMET recommends a five- step process to develop 
a COS: define the scope, assess the need, develop the 
protocol, determine what to measure and determine how 
to measure.52 This systematic review addresses these first 
two steps for the development of the COS in TBPI care. 
This review has shown the majority of TBPI studies use 
only clinician reported outcomes to evaluate interven-
tions. However, they do not adequately capture patients’ 
health- related quality of life,53 and may underestimate the 
impact of a condition.54 Concurrent qualitative work to 
identify outcomes which are important to individuals with 
a TBPI has been completed by this group. The next stage 
involves integration of all potential outcomes from this 
review and the qualitative work into a long list of domains. 
Healthcare professionals and patients will be invited to 
prioritise these outcomes during a three- round interna-
tional online Delphi process and consensus meeting. This 
will strengthen the case for uptake of a COS for TBPI as it 
represents patients’ and clinicians’ perspectives on what 
outcomes are important. The final stage will map existing 
validated measures to the outcome domains in the final 
COS. A future study will evaluate the psychometric prop-
erties of those mapped measurement instruments and 
identify where new measures need to be developed.
CONCLUSION
This systematic review has shown that outcome reporting 
in TBPI care is heterogenous and impairment focused 
with a lack of standardised definitions for commonly 
reported outcomes. This makes it difficult to compare and 
combine data from studies to inform decision- making in 
clinical practice. The measurement instruments used in 
the studies were also often not clear, particularly when 
range of movement was assessed. In future studies, authors 
need to be clearer with descriptions of outcomes assessed 
and how they were measured. Less than half the studies 
in this review evaluated outcomes using PRO measures. 
Given that TBPI has a significant impact on health- 
related quality of life, it is recommended that authors of 
future studies include PROs in future studies. We have 
identified a list of potentially relevant outcomes and cate-
gorised these into a clear taxonomy. This will inform the 
next stage of developing a COS for TBPI where patients, 
surgeons and therapists will be involved in a consensus 
process to decide the final outcomes included in a COS 
for TBPI.
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